Seres Therapeutics
D

MCRB

2.10000
USD
0.00
(0.00%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
674
الربح لكل سهم
-4
العائد الربحي
-
P/E
-1
حجم السوق
21,094,040
أصول ذات صلة

العنوان: Seres Therapeutics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.